Insights

Market leadership Lumea is the US leader in primary clinical digital pathology with high-volume capabilities and AI-driven workflows, presenting a strong value proposition for large healthcare systems seeking scalable pathology solutions.

Expansion potential Global presence across five continents and a substantial U.S. market share in urology, dermatology, and gastroenterology indicate opportunities to upsell across specialties and geographies, including international accounts seeking mature digital pathology ecosystems.

ROI and efficiency Emphasize measurable ROI through tissue integrity optimization, improved detection rates, and workflow efficiency to appeal to networks and hospital systems focused on cost containment and diagnostic accuracy.

Tech stack leverage Leverage AI-driven workflows and modern tech foundations (PWA, AMP, HTTP/3, analytics) to position Lumea as a future-ready partner for health systems pursuing interoperable, fast, and robust digital pathology solutions.

Strategic partnerships Target large dermatology, urology, and gastroenterology networks, academic centers, and pathology groups seeking scale, data capabilities, and standardized tissue-handling to accelerate adoption and renewals.

Similar companies to Lumea

Lumea Tech Stack

Lumea uses 8 technology products and services including Criteo, Cart Functionality, Lightbox, and more. Explore Lumea's tech stack below.

Criteo
Advertising
Cart Functionality
E-commerce
Lightbox
Javascript Libraries
Elementor
Page Builders
PHP
Programming Languages
Cloudflare Bot Management
Security
Google Search Console
Web Analytics
Microsoft ASP.NET
Web Frameworks

Media & News

Lumea's Email Address Formats

Lumea uses at least 4 format(s):

Lumea Email Formats	Example	Percentage
First@lumea.net	John@lumea.net	91%
First.Last@lumea.net	John.Doe@lumea.net	9%
First@lumea.org	John@lumea.org	57%
Last@lumea.org	Doe@lumea.org	39%
First.Last@lumea.org	John.Doe@lumea.org	4%
First@lumeadigital.com	John@lumeadigital.com	64%
First.Last@lumeadigital.com	John.Doe@lumeadigital.com	36%
First@tinyurl.com	John@tinyurl.com	78%
FirstLast@tinyurl.com	JohnDoe@tinyurl.com	21%
Middle@tinyurl.com	Michael@tinyurl.com	1%

Frequently Asked Questions

What is Lumea's official website and social media links?

Lumea's official website is tinyurl.com and has social profiles on LinkedIn.

How much revenue does Lumea generate?

As of July 2026, Lumea's annual revenue is estimated to be $50M - $100M.

What is Lumea's NAICS code?

Lumea's NAICS code is 5112 - Software Publishers.

How many employees does Lumea have currently?

As of July 2026, Lumea has approximately 66 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Scientific Officer: M. E.Regional Lead – Sales, Bd & Operations-Digital Pathology (asia, Middle East & Southeast Asia): A. P.Client Success Manager & Supervisor Of Customer Support: C. B.. Explore Lumea's employee directory with LeadIQ.

What industry does Lumea belong to?

Lumea operates in the Software Development industry.

What technology does Lumea use?

Lumea's tech stack includes CriteoCart FunctionalityLightboxElementorPHPCloudflare Bot ManagementGoogle Search ConsoleMicrosoft ASP.NET.

What is Lumea's email format?

Lumea's email format typically follows the pattern of First@lumea.net. Find more Lumea email formats with LeadIQ.

When was Lumea founded?

Lumea was founded in 2014.

Lumea

Q: What is Lumea's official website and social media links?

Lumea's official website is tinyurl.com. Lumea has social profiles on LinkedIn.

Q: How many employees does Lumea have currently?

Lumea has approximately 66 employees.

Q: What technology does Lumea use?

Lumea's tech stack includes Google Workspace, HSTS, 33Across, Google AdSense, Cloudflare.

Q: What is Lumea's NAICS code?

Lumea's NAICS code is 5112 (Software Publishers).

Software DevelopmentUtah, United States51-200 Employees

Lumea is a software development company based in Lehi, Utah, that focuses on primary clinical digital pathology. It handles the highest volume of primary digital diagnoses in the United States, reflecting its position in the market. With more than a decade of experience, the company combines tissue-handling capabilities with AI-enabled workflows to improve efficiency and the quality of cancer diagnostics. Globally, Lumea operates across five continents and supports a broad base of customers, including a substantial share of the U.S. urology market and leading dermatology and gastroenterology groups. By preserving tissue integrity, enhancing detection rates, and delivering measurable ROI, it aims to make pathology more precise and efficient for its clinical partners.